Cidara Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 302K | 973K | 17.6M |
| Cost of Goods Sold | 45.0M | 24.8M | 24.6M | 46.9M | 12.4M | 0 | 5.9M | 1.1M |
| Gross Profit | -45.0M | -24.8M | -24.6M | -46.9M | -12.4M | 302K | -4.9M | 16.4M |
| R&D Expenses | 35.5M | 24.8M | 24.6M | 46.9M | 12.4M | 6.7M | 5.9M | 15.4M |
| Operating Expenses | 43.6M | 2.6M | 669K | 7.3M | 5.0M | 96.3M | 3.6M | 22.5M |
| Operating Income | -88.6M | -27.4M | -25.3M | -54.2M | -17.4M | -96.0M | -8.5M | -6.1M |
| Other Income / Gains | 5.4M | 1.7M | 1.8M | 1.8M | 1.9M | 1.8M | 365K | 527K |
| Net Income | -83.2M | -25.7M | -23.5M | -52.3M | -16.0M | -91.2M | -10.3M | -5.6M |
| EPS (Diluted) | -3.10 | -1.65 | -1.66 | -5.37 | -2.38 | -19.59 | -2.28 | -1.25 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 1.00 | -5.083 | 0.935 |
| General And Administrative Expenses | 8.1M | 6.5M | 6.2M | 20.6M | 5.0M | 4.7M | 3.6M | 7.2M |
| Selling And Marketing Expenses | 0 | 0 | 0 | -13.3M | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 8.1M | 6.5M | 6.2M | 7.3M | 5.0M | 4.7M | 3.6M | 7.2M |
| Other Expenses | 0 | -28.8M | -30.1M | -46.9M | -12.4M | 84.9M | -5.9M | 0 |
| Cost And Expenses | 88.6M | 27.4M | 25.3M | 54.2M | 17.4M | 96.3M | 9.5M | 23.7M |
| Interest Income | 5.4M | 1.7M | 1.9M | 1.8M | 1.9M | 1.8M | 365K | 527K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 28K | 27K | 49K | 59K | 61K | 57K | 36K | 39K |
| Ebitda | -83.2M | -25.7M | -23.4M | -52.3M | -15.5M | -11.0M | -8.1M | -5.5M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | -36.57 | -8.367 | -0.313 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | -317.828 | -8.779 | -0.345 |
| Income Before Tax | -83.2M | -25.7M | -23.5M | -52.4M | -15.5M | -94.2M | -8.2M | -5.5M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | -311.954 | -8.404 | -0.315 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 64K |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | -302.017 | -10.613 | -0.319 |
| Epsdiluted | -3.10 | -1.65 | -1.66 | -5.37 | -2.38 | -19.59 | -2.28 | -1.24 |
| Weighted Average Shs Out | 15.5M | 15.5M | 14.2M | 9.7M | 6.5M | 4.6M | 4.5M | 4.5M |
| Weighted Average Shs Out Dil | 15.5M | 15.5M | 14.2M | 9.7M | 6.5M | 4.6M | 4.5M | 4.5M |